[ad_1] Gilead Sciences’ Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. In a letter sent to…
Tag: Gilead
Gilead Axes Jobs After Introducing ‘refreshed business strategy’
[ad_1] 1 December 2023 Pharmaceutical Approximately 7% of Gilead Sciences’ personnel will be laid off as a result of a business evaluation being conducted on the company’s Kite Pharma cell…
AHF Protests ‘Greedy Gilead’ for Price Gouging
[ad_1] AHF Protests ‘Greedy Gilead’ for Price Gouging | West Virginia … WV News [ad_2] Source link
AHF Slams Gilead Profiteering
[ad_1] AHF Slams Gilead Profiteering | West Virginia Business News … WV News [ad_2] Source link
‘Responsible Investors: Dump Gilead’ Says AHF Ad
[ad_1] ‘Responsible Investors: Dump Gilead’ Says AHF Ad | West Virginia … WV News [ad_2] Source link
Gilead Sciences and Meharry Medical College Highlight Five-Year Impact of Gilead COMPASS Initiative® on HIV in the Southern United States
[ad_1] – Journal Of Health Care for the Poor and Underserved Supplement Details COMPASS Progress at the Halfway Mark of the Ten-Year Initiative – FOSTER CITY, Calif. & NASHVILLE, Tenn.–(BUSINESS…
Gilead Sciences battles U.S. government in court over HIV prevention patent
[ad_1] Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021. (Photo by Jakub Porzycki/NurPhoto…
Gilead Sciences to Release First Quarter 2023 Financial Results on Thursday, April 27, 2023
[ad_1] April 13, 2023 Gilead Sciences to Release First Quarter 2023 Financial Results on Thursday, April 27, 2023 FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) announced today…
Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics – ResearchAndMarkets.com
[ad_1] Germany Cell and Gene Therapy Market Report 2023: Players … WV News [ad_2] Source link
Opinion | Gilead Sciences Is the Target of a Bizarre Legal Theory
[ad_1] A lawsuit claims the biotech innovator should have rolled out a new drug sooner. [ad_2] Source link